Technology
The new and enhanced VIST Enhanced Carotid and Coronary 7.7 training modules feature vital signs, complications, medication management and measurement functionality enhance to create clinical realism and elevate the educational value of simulation training. The system includes new patient cases, including chronic total occlusion and transradial access.
May 26, 2009
News
May 26, 2009 – AMG International GmbH last week submitted its second-generation drug-eluting stent (DES), Itrix, for regulatory review in Europe. The stent offers a bioabsorbable polymer that holds the drug.
May 26, 2009
Technology
May 26, 2009 – Biotronik Inc. recently launched its Lumax 540 series implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillator (CRT-D) devices during Heart Rhythm 2009.
May 26, 2009Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
May 26, 2009 – Medtronic intends to seek FDA approval for the use of cardiac resynchronization therapy (CRT) in certain mildly symptomatic heart failure patients. While CRT is a proven life-saving therapy for some patients with advanced stages of heart failure (New York Heart Association Class III, IV), it is not currently approved for use in earlier stages, or mildly symptomatic patients.
May 26, 2009News
May 26, 2009 - United Therapeutics Corp. said today the FDA approved ADCIRCA (tadalafil) tablets for oral administration, with a recommended dose of 40 mg, as the first once-daily phosphodiesterase type 5 (PDE5) inhibitor for the treatment of pulmonary arterial hypertension (PAH).
May 26, 2009
Technology
May 22, 2009 - Rafael Medical Technologies Inc. said this week it received FDA clearance for its SafeFlo Vena Cava Filter. The clearance is for the permanent implantation of the filter in patients at risk of pulmonary embolism. CE mark was granted for the filter in 2004 for both permanent and retrieval indications.
May 22, 2009Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
May 22, 2009 - CPC of America Inc. filed its first patent of a synthetic sealant for the MedClose Vascular Closure System (VCS), which is an internal puncture-closing system for use in percutaneous intravascular diagnostic and interventional procedures.
May 22, 2009News
May 22, 2009 - According to IMV’s recent census of cath labs in the U.S., starting in 2007 the total number of patient cases declined, with a 10 percent decline from 4.21 million in 2006 to 3.8 million in 2007, and a slight decrease of 1 percent to 3.75 million in 2008.
May 22, 2009
News
May 21, 2009 - Boston Scientific Corp. this week announced results from an analysis of economic and quality of life outcomes, based on one-year data from its landmark SYNTAX trial.
May 22, 2009Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
May 22, 2009 – Biotronik said today it is partnering with Belgian biotechnology company Cardio3 BioSciences in its C-Cure stem cell clinical trial, where it will provide implantable cardioverter defibrillators (ICDs) with home monitoring.
May 21, 2009
News
May 22, 2009 - New data presented yesterday at EuroPCR from an international, post-approval, single-arm study show that Abbott's XIENCE V Everolimus Eluting Coronary Stent System demonstrated low rates of repeat procedure (target lesion revascularization), stent thrombosis and major adverse cardiac events (MACE) in a complex patient population.
May 21, 2009
News
May 21, 2009 - LightLab Imaging Inc. this week is launching its next generation optical coherence tomography (OCT) system, the C7XR FD-OCT Imaging System with the C7 Dragonfly Imaging Catheter, at EuroPCR 2009 in Barcelona, Spain.
May 21, 2009Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
May 21, 2009 - Direct Flow Medical Inc. this week announced the first human use of its new 18 Fr. Percutaneous Aortic Valve (PAV) System, to successfully treat two high-risk surgical candidates at Dante Hospital in San Paolo, Brazil.
May 21, 2009
News
May 21, 2009 - InspireMD Ltd. said today it completed enrollment for the MAGICAL Trial (MGuard in Acute Myocardial), which is designed to confirm the clinical feasibility, safety and performance of MGuard when used during primary PCI in STEMI patients.
May 21, 2009
News
May 21, 2009 – Edwards Lifesciences Corp. last week announced the successful completion of the first human implants of its next-generation transcatheter aortic heart valve used with its new 18 Fr. delivery system.
May 20, 2009© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now